Li Ning Li
Directeur/Bestuurslid bij HaploX Investment Holding Ltd.
Actieve functies van Li Ning Li
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
HaploX Investment Holding Ltd.
HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | Directeur/Bestuurslid | 29-01-2023 | - |
Loopbaan van Li Ning Li
Eerdere bekende functies van Li Ning Li
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Grains Valley Venture Capital | Operationeel Directeur | 01-01-2009 | 02-01-2009 |
Opleiding van Li Ning Li
University of Cardiff | Graduate Degree |
China Pharmaceutical University | Undergraduate Degree |
Statistieken
Internationaal
China | 3 |
Verenigd Koninkrijk | 2 |
Kaaimaneilanden | 2 |
Operationeel
Director/Board Member | 1 |
Chief Operating Officer | 1 |
Undergraduate Degree | 1 |
Sectoraal
Consumer Services | 3 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Grains Valley Venture Capital | |
HaploX Investment Holding Ltd.
HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | Commercial Services |
- Beurs
- Insiders
- Li Ning Li
- Ervaring